Sugar Spheres Market is Expected to Reach USD 278.2 Million by 2030
As per the report published by Kings Research, the global Sugar Spheres Market was valued at USD 164.2 million in 2022 and is projected to reach USD 278.2 million by 2030, growing at a CAGR of 7.0% from 2023 to 2030.
The market is expanding rapidly owing to the accelerating demand for long-term drug delivery systems, increasing chronic diseases, and proliferating demand for food & dietary supplements are the factors driving the growth of the sugar spheres market. The market growth is driven by the increasing investment in research & development, technological advancements in the industry, and growing demand for innovative and effective drug delivery systems, along with increasing demand for pharmaceuticals, food, and nutraceuticals, which is expected to drive the growth of the market over the forecast period. Several drug manufacturers are exploring the use of 3D printing to create customized oral dosage forms. Sugar spheres can act as a scaffold on which drugs can be layered to create complex structures with precise geometry and controlled release properties. Moreover, these innovations in sugar sphere production technology show their potential as versatile and key excipients in the end-user industries.
- Based on product, the standard spheres segment is growing at a CAGR of 6.3% over the forecast period
- Based on application, the tablet segment is the dominating segment with a market revenue of USD 105.6 million in 2022
- On the basis of region, Europe accounted largest market value of USD 62.6 million in 2022
Manufacturing of Pharmaceutical Tablets and Capsules Using Sugar Spheres Drives Market Growth
The use of sugar granules as excipients in the preparation of pharmaceutical tablets and capsules has become increasingly popular due to their versatility and effectiveness in drug delivery systems. Sugar spheres are inert cores or fillers used to give a uniform size and shape to a tablet or capsule and can be coated layer by layer with an active ingredient or other fillers. This approach enables the development of long-acting, sustained-release, or delayed-release formulations. In addition, the use of sugar spheres enables the development of long-acting, long-acting, or delayed-release formulations, which help improve patient compliance and reduce dosing frequency. The coating process allows the active ingredient or other excipients to be applied in a controlled manner, resulting in the desired release profile. In summary, sugar balls are an essential part of the development of new drug delivery systems in the pharmaceutical industry.
Technological Innovations and Developments in the Sugar Sphere Augments the Market Growth
Technological advances in the production of sugar sphere is the use of spray drying techniques. These innovations and developments aim to improve the functional properties of sugar spheres and expand their applications in the pharmaceutical industry. In the spray drying process, the sugar solution is sprayed into small droplets that dry quickly with hot air or nitrogen gas. This process produces sugar spheres with a narrow particle size distribution and improved followability, making them suitable for use in direct compression and high-speed tableting operations. The other innovation in the use of sugar spheres is the development of functional coatings that improve drug stability and bioavailability. These coatings can be designed to provide pH-sensitive, time-controlled, or targeted release of the active ingredient, improving their effectiveness in drug delivery systems. In addition, recent developments have focused on the production of sugar spheres from other natural sources such as polysaccharides and proteins. Polysaccharides such as chitosan and cellulose have been investigated for their biodegradability, biocompatibility, and low toxicity. Furthermore, the production of sugar spheres from proteins such as soy and whey has been investigated due to their unique functional properties, including their ability to improve drug stability and bioavailability.
North America is the Second Dominating Region with a Projected CAGR of 6.79%
The growing preference for natural and organic ingredients in consumer products is another factor driving the growth of the market. Consumers are becoming increasingly health conscious and are focusing on products that contain natural or organic ingredients, ensuring an increase in demand for such products. In addition, stringent regulations in Europe have also led to the development of high-quality sugar spheres that meet the standards of the European pharmaceutical industry.
Asia Pacific Region is the Fastest Growing Region with a Market Share of 25% in 2022
The sugar sphere market in the Asia Pacific region is proliferated by the increasing number of chronic diseases and the expansion of the pharmaceutical industry. Ongoing technological advancements in manufacturing and drug delivery systems are expected to drive innovation and market growth, contributing to economic development in the region. Increased investments in research and development and technological development in production have also led to the development of high-quality sugar spheres across the APAC region.
Key Players are Focusing on Expanding their Product Portfolio to Expand their Geographical Reach
The global sugar sphere market is fragmented with key players viz., Colorcon, Cornileus Pharmaceuticals (P) Ltd., Dhanraj Sugars PVT. Ltd., Emilio Castelli S.a.s., B. Sugars and Pharmaceuticals Limited, Meenaxy Pharma Private Limited (MPPL), Nanjing Joyfulchem Co., Ltd., Pharma Excipients International AG, Pharmatrans-Sanaq AG, Volza, and others. Companies are employing a variety of strategic measures such as acquisitions, mergers, partnerships, product introductions, and collaborations to expand their business globally and enhance their competitive position.